The treatment of OVX mice with IL-18BP prevented bone loss, and in women with osteoporosis, IL-18BP levels decreased while serum IL-18 levels increased (188), suggesting that IL-18BP may be used to treat postmenopausal osteoporosis. The gene discussed is IL18BP; the disease is postmenopausal osteoporosis.